Scientists at the University of Oxford have developed a new method to 3D-print laboratory-grown cells to form living structures.
The approach could revolutionise regenerative medicine, enabling the production of complex tissues and cartilage that would potentially support, repair or augment diseased and damaged areas of the body.
Printing high-resolution living tissues is hard to do, as the cells often move within printed structures and can collapse on themselves. But, led by Professor Hagan Bayley, Professor of Chemical Biology in Oxford’s Department of Chemistry, the team devised a way to produce tissues in self-contained cells that support the structures to keep their shape.
The cells were contained within protective nanolitre droplets wrapped in a lipid coating that could be assembled, layer-by-layer, into living structures. Producing printed tissues in this way improves the survival rate of the individual cells, and allowed the team to improve on current techniques by building each tissue one drop at a time to a more favourable resolution.
To be useful, artificial tissues need to be able to mimic the behaviours and functions of the human body. The method enables the fabrication of patterned cellular constructs, which, once fully grown, mimic or potentially enhance natural tissues.
Dr Alexander Graham, lead author and 3D Bioprinting Scientist at OxSyBio (Oxford Synthetic Biology), said: ‘We were aiming to fabricate three-dimensional living tissues that could display the basic behaviours and physiology found in natural organisms. To date, there are limited examples of printed tissues, which have the complex cellular architecture of native tissues. Hence, we focused on designing a high-resolution cell printing platform, from relatively inexpensive components, that could be used to reproducibly produce artificial tissues with appropriate complexity from a range of cells including stem cells’.
The researchers hope that, with further development, the materials could have a wide impact on healthcare worldwide. Potential applications include shaping reproducible human tissue models that could take away the need for clinical animal testing.
Over the coming months they will work to develop new complementary printing techniques, that allow the use of a wider range of living and hybrid materials, to produce tissues at industrial scale. Dr Sam Olof, Chief Technology Officer at OxSyBio, said: ‘There are many potential applications for bioprinting and we believe it will be possible to create personalised treatments by using cells sourced from patients to mimic or enhance natural tissue function. In the future, 3D bio-printed tissues maybe also be used for diagnostic applications – for example, for drug or toxin screening.’
Learn more: A new method of 3D printing living tissues
The Latest on: Regenerative medicine
- LifeNet Health establishes world's first dedicated regenerative medicine logistics and distribution center in Indianapolison October 15, 2019 at 5:08 pm
Oct. 15, 2019 /PRNewswire/ -- LifeNet Health, a global leader in regenerative medicine, today opened a technologically advanced logistics and distribution center in Indianapolis. This state-of-the-art ...
- BRIEF—Anglo-Japanese partnership in regenerative medicineon October 15, 2019 at 2:58 pm
The UK’s Biotechnology Association (BIA) and Japan’s Forum for Innovative Regenerative Medicine (FIRM) have agreed a collaboration. Their partnership is aimed at helping UK and Japanese companies in ...
- Global Regenerative Medicine Market Size and Forecast To 2026on October 15, 2019 at 4:28 am
Oct 15, 2019 (AmericaNewsHour) -- Regenerative Medicine Market Analysis According to Verified Market Research, the Global Regenerative Medicine Market was valued at USD 19.10 Billion in 2018 and is ...
- Global Regenerative Medicine Market to witness heavy growth prospects via manufacturing sector up to 2024on October 15, 2019 at 2:42 am
Oct 15, 2019 (Market Research Analyst via COMTEX) -- The report mainly studies the size, recent trends and development status of the Regenerative Medicine market, as well as investment opportunities, ...
- Regenerative Medicine Firm Recognized for Innovative Wound Care Biotechnologyon October 11, 2019 at 5:08 pm
Phoenix-based BioLab Sciences gains traction in regenerative medicine market, landing three national awards including Top 10 Wound Care Solution Provider BioLab Sciences, a regenerative biotechnology ...
- Medicine by Design to accelerate regenerative medicine discovery and translation with new $20-million investmenton October 11, 2019 at 11:52 am
... Shana Kelley of the Leslie Dan Faculty of Pharmacy are leading two of the teams that Medicine by Design is funding Medicine by Design is strengthening the University of Toronto as a global leader ...
- Medicine by Design to accelerate regenerative medicine discovery and translation withon October 11, 2019 at 11:43 am
Medicine by Design is strengthening the University of Toronto as a global leader in regenerative medicine with a new investment of as much as $20 million in research that will accelerate stem cell and ...
- The World Market for 3D Bioprinting (2019-2024): Growing Demand for Regenerative Medicine & Stem Cell Research Presents Opportunitieson October 9, 2019 at 12:15 pm
The demand for research applications is further sub-segmented into drug research, regenerative medicine, and 3D cell culture. Among these, the drug research segment accounted for the largest share of ...
- End your pain NOW with AZ Regenerative Medicineon October 8, 2019 at 9:55 am
AZ Regenerative Medicine is a paid advertiser of Sonoran Living. Dr. Jeffrey W. Frost has over 25 years of experience as a chiropractor. He started at Lincoln Chiropractic Clinics and is now the owner ...
- Wake Forest regenerative medicine researchers gain $24M federal grant for body-on-a-chip studyon October 8, 2019 at 9:46 am
The innovative "lung-on-a-chip" regenerative medicine technology in Wake Forest Baptist Medical Center has received $24 million in federal grant funding. The grant, announced Tuesday by the U.S.
via Google News and Bing News